Concepedia

Diana Ramirez-Ardila

DR

3

Publications

152

Citations

3

H-Index

2013

Active since

Affiliations

GZA Ziekenhuizen Campus Sint-Augustinus(Current)

Erasmus MC Cancer Institute

KU Leuven

The Netherlands Cancer Institute

University of Antwerp

Diana Ramirez-Ardila is an author at GZA Ziekenhuizen Campus Sint-Augustinus specializing in pharmacotherapy, cancer research, and cancer therapeutics.

Top concepts

Publications per year

2013–2016

3

Publications

3

Decreased expression of ABAT and STC2 hallmarks ER‐positive inflammatory breast cancer and endocrine therapy resistance in advanced disease

Maurice P.H.M. Jansen, Leen Sas, Anieta M. Sieuwerts et al. · Molecular Oncology · 2015 · 63 citations · Full text

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen

Diana Ramirez-Ardila, Jean Helmijr, Maxime P. Look et al. · Breast Cancer Research and Treatment · 2013 · 56 citations

, , +12

LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome

Diana Ramirez-Ardila, Kirsten Ruigrok-Ritstier, Jean Helmijr et al. · Molecular Oncology · 2016 · 33 citations · Full text

Rows per page

1–3 of 3